Clinical Trial Update: Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the optimal duration of therapeutic hypothermia for neuroprotection after pediatric cardiac arrest has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Cardiac Arrest

Snippet

Sponsor: University of Pittsburgh | Conditions: Cardiac Arrest, Brain Injury | Phase 2 | Status: COMPLETED